Phase 2
This is a multicenter, randomized, double-blind, placebo-controlled, cross-over study to evaluate the efficacy and safety of AVTX-801 in subjects with SLC35A2-…
SLC35A2-CDG - Solute Carrier Family 35 Member A2 Congenital Disorder of Glycosylation